Co-founder and CSO of our new start-up redefining the treatment of age-related diseases by boosting the body's ability to withstand the damage of aging.

Wide range of technical advice and consulting on the life sciences and their use in start-ups. Held Board positions on SULIS Seed Fund, Iceni Fund Advisory Group, Karus Therapeutics, Glythera Ltd.. Included spending 14 years teaching a 40-hour core module at Cambridge University's Masters in Bioscience Enterprise programme (https://www.postgraduate.study.cam.ac.uk/courses/directory/egcempbse).

Researcher in Prof Sara Seager's group at MIT, working out how we might detect alien biochemistries on other worlds. Computational chemistry and biochemistry work with a world-class physicist.

Start-up researching innovative anti-aging concept based on mitochondrial biology. Took the company from concept through seed funding to proof-of-concept experiments. Company was wound up when these did not pan out.

Founder of a start-up deploying innovative chemistry to drug discovery. Took the company through seed and series A financing, filed initial patents and recruited CEO to take the company forward.